Next Gen CRISPR Therapies with Trevor Martin, CEO of Mammoth Biosciences

This is a free preview of a paid episode. To hear more, visit www.mendelspod.com

Chapters:0:00 Novel Cas enzymes help overcome CRISPR challenges11:37 New pipeline of therapies will go after novel targets14:52 How does the new platform open up possibilities for new diagnostics?21:05 What risks do you think about?26:47 What are the company’s two-year goals?31:07 On the possibilitiesCRISPR technology is enabling a new generation …